Spending on prescription drugs topped $300 billion in the U.S. last year, rising 5.1% despite the economic downturn, according to IMS Health. But the rate of growth was at the low end of historical levels, reinforcing the difficulties brand-name drug makers face relying on the U.S. market to increase revenue. The number of prescriptions dispensed in the U.S. also edged higher last year, increasing 2.1% to 3.9 billion, IMS Health reported. IMS Health collects data from drug makers, pharmacies and other prescription drug dispensing outlets.
Steve - most of the economy is in the tank, but prescriptions and profits keep flowing.
No comments:
Post a Comment